Cargando…
Atherosclerosis treatment with nanoagent: potential targets, stimulus signals and drug delivery mechanisms
Cardiovascular disease (CVDs) is the first killer of human health, and it caused up at least 31% of global deaths. Atherosclerosis is one of the main reasons caused CVDs. Oral drug therapy with statins and other lipid-regulating drugs is the conventional treatment strategies for atherosclerosis. How...
Autores principales: | Luo, Ting, Zhang, Zhen, Xu, Junbo, Liu, Hanxiong, Cai, Lin, Huang, Gang, Wang, Chunbin, Chen, Yingzhong, Xia, Long, Ding, Xunshi, Wang, Jin, Li, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315585/ https://www.ncbi.nlm.nih.gov/pubmed/37404681 http://dx.doi.org/10.3389/fbioe.2023.1205751 |
Ejemplares similares
-
Targeting and functional effects of biomaterials-based nanoagents for acute pancreatitis treatment
por: Cai, Yujie, et al.
Publicado: (2023) -
The Feasibility of Targeted Magnetic Iron Oxide Nanoagent for Noninvasive IgA Nephropathy Diagnosis
por: Wu, Yaoyao, et al.
Publicado: (2021) -
Intelligent Bimetallic Nanoagents as Reactive Oxygen Species Initiator System for Effective Combination Phototherapy
por: Li, Hongfeng, et al.
Publicado: (2020) -
Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis
por: Cervadoro, Antonio, et al.
Publicado: (2018) -
The Relationship Between Nutrition and Atherosclerosis
por: Wei, Taotao, et al.
Publicado: (2021)